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Background: Previous screening of the substrate repertoires and substrate specificity profiles of granzymes resulted
in long substrate lists highly likely containing bystander substrates. Here, a recently developed degradomics
technology that allows distinguishing efficiently from less efficiently cleaved substrates was applied to study the
degradome of mouse granzyme B (mGrB).
Results: In vitro kinetic degradome analysis resulted in the identification of 37 mGrB cleavage events, 9 of which
could be assigned as efficiently targeted ones. Previously, cleavage at the IEAD75 tetrapeptide motif of Bid was
shown to be efficiently and exclusively targeted by human granzyme B (hGrB) and thus not by mGrB. Strikingly,
and despite holding an identical P4-P1 human Bid (hBid) cleavage motif, mGrB was shown to efficiently cleave
the BCL2/adenovirus E1B 19 kDa protein-interacting protein 2 or BNIP-2 at IEAD28. Like Bid, BNIP-2 represents a
pro-apoptotic Bcl-2 protein family member and a potential regulator of GrB induced cell death. Next, in vitro
analyses demonstrated the increased efficiency of human and mouse BNIP-2 cleavage by mGrB as compared to
hGrB indicative for differing Bid/BNIP-2 substrate traits beyond the P4-P1 IEAD cleavage motif influencing cleavage
efficiency. Murinisation of differential primed site residues in hBNIP-2 revealed that, although all contributing, a single
mutation at the P3′ position was found to significantly increase the mGrB/hGrB cleavage ratio, whereas mutating the
P1′ position from I29 > T yielded a 4-fold increase in mGrB cleavage efficiency. Finally, mutagenesis analyses revealed
the composite BNIP-2 precursor patterns to be the result of alternative translation initiation at near-cognate start sites
within the 5′ leader sequence (5′UTR) of BNIP-2.
Conclusions: Despite their high sequence similarity, and previously explained by their distinct tetrapeptide specificities
observed, the substrate repertoires of mouse and human granzymes B only partially overlap. Here, we show that the
substrate sequence context beyond the P4-P1 positions can influence orthologous granzyme B cleavage efficiencies to
an unmatched extent. More specifically, in BNIP-2, the identical and hGrB optimal IEAD tetrapeptide substrate motif is
targeted highly efficiently by mGrB, while this tetrapeptide motif is refractory towards mGrB cleavage in Bid.
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While gene orthology implies homology between two
genes separated by a speciation event, no conclusions
regarding their full functional equivalence can be simply
extrapolated. Contradictions in literature on apparent
isofunctional orthologs are thus partly due to the fact that
incorrect functional extrapolations between orthologous
genes were made. Human granzyme B (hGrB), a protease
belonging to a family of serine proteases present in the
granules of cytotoxic lymphocytes (cytotoxic T lympho-
cytes and natural killer cells) and implicated in the induc-
tion of cell death, was shown to display distinct functional
and structural characteristics as compared to its murine
ortholog despite their 80% amino acid similarity and 70%
amino acid identity [1-4]. Positional scanning synthetic
combinatorial libraries, phage display data and proteome-
wide degradome analyses all aided in the elucidation of
the differential specificity profiles and substrate repertoires
of these orthologous granzymes [1-5]. Next to the higher
cytotoxicity of hGrB, differences in cleavage efficiencies
of Bid and caspase-3, substrates known to be of critical
importance for the execution of hGrB induced cell
death, were found for the human and mouse orthologous
granzymes B [2-4]. While hGrB is capable of cleaving Bid
and caspase-3 orthologs with comparable cleavage effi-
ciencies, mGrB is unable to process Bid and cleaves mouse
caspase-3 about 12-fold more efficient as compared to
human caspase-3 [4]. Differential positional proteomics
analyses furthermore reported on a proteome-wide
analysis of the extended specificity profiles (i.e., beyond
cleavage positions P4-P1) of both orthologous granzymes,
and showed enhanced mGrB versus hGrB cleavage efficien-
cies of substrates holding Lys and Gly residues in the P1′
and P2′ positions respectively (Pn-…-P2-P1-P1′-P2′-…-Pn’
nomenclature according to Schechter and Berger [6])
amongst other (subtle) distinct substrate traits [1].
The ability to separate critical from bystander cleavage
events may also aid in elucidating the different underlying
mechanisms of action engaged by these orthologous
granzymes when exerting their primary functions [7-9].
Despite hindering a direct extrapolation to the physio-
logical importance of mGrB-induced cleavages, distinct-
ive orthologous granzyme B substrate traits can be
captured using identical proteome backgrounds. As such,
and in line with a previously developed positional proteo-
mics strategy to follow substrate cleavage kinetics [8], we
here made use of a human proteome background for
identifying mGrB cleavage events. In this pioneering study
on hGrB, of the 101 hGrB cleavage sites identified, only 18
were found to be efficiently cleaved, including cleavage at
IEAD75 in the BH3-interacting domain death agonist Bid
[Swiss-Prot: P55957] and at IEAD28 in the pro-apoptotic
Bcl-2 family member BNIP-2 [Swiss-Prot: Q12982] [10,11].
While Bid stands central in hGrB induced apoptosis [12],both human and mouse Bid were found to be very poor
mGrB substrates [1-4]. The essential requirement of Bid
cleavage for hGrB-induced cell death [13] and the Bid inde-
pendent cytotoxicity of mGrB [14], led to the postulation
that mGrB exerts its cytotoxicity via direct activation of an
effector caspase (i.e., caspase 3 and/or 7) [2], by relieving
IAP inhibition of caspase-3, as shown for hGrB [15], and/or
by the direct cleavage of yet unidentified substrates.
To explore these hypotheses, we applied our degrado-
mics technology to probe for efficient mGrB cleavage
events. Next to caspase-7, and in analogy with a previous
analysis probing for efficient hGrB cleavage events [8],
BNIP-2 cleavage was here assigned amongst the most effi-
ciently cleaved mGrB substrates. Members of the family of
pro-apoptotic Bcl-2 and adenovirus E1B 19 kDa inter-
acting proteins to which BNIP-2 belongs, are known to
interact with various pathological and physiological
anti-apoptotic proteins such as Bcl-2 and the adenoviral
E1B 19 kDa protein [16]. In addition to several other
domains, BNIP-2 holds a BNIP-2 and Cdc42GAP hom-
ology (BCH) domain (Figure 1), via which it is able to
bind cdc42, a member of the Rho subfamily involved in
controlling cell morphological changes, to promote the
formation of cellular extensions [17] and myogenic dif-
ferentiation via yet unidentified regulator(s) [18].
Besides its implication in cellular differentiation, other
functions have been attributed to BNIP-2 [19], including
its involvement in apoptotic signaling (for human as well
as mouse BNIP-2). Massive cell death of neuroblastoma
cells occurs following overexpression of hBNIP-2, and is
counteracted by treatment with neuroprotective estrogen,
which results in a downregulation of hBNIP-2 [20]. These
findings inspired several groups to study the molecular
mechanisms underlying hBNIP-2 induced apoptosis.
Interestingly, in vitro and/or in cellulo cleavage of hBNIP-
2 by the caspases 3, 6, 8, 9 and 10 occurs outside the BCH
domain [21,22]. In addition, GrB mediated cleavage of
hBNIP-2 could be observed when probing for human and
mouse granzyme B substrates [1], a hGrB event further-
more predicted by a database search making use of the
optimal Bid cleavage motif (i.e., IEAD) [11]. Human
BNIP-2 was found to be directly processed at IEAD28
by granzyme B in vitro and during natural killer cell-
mediated killing of tumor cells and thus not secondary
to granzyme B induced caspase activation [11]. Although
these data could suggest that caspase/granzyme-mediated
release of the BCH domain influences the pro-apoptotic
activity of BNIP-2, in line with the observed massive
neuroblastoma cell death [20], full length hBNIP-2 by
itself was able to induce cell death in HeLa cells [11].
Various signaling pathways, including activation of the
intrinsic apoptotic pathway [23] or direct caspase activa-
tion [24], have been proposed to explain the apoptotic
potential of BNIP-2.
Figure 1 Domain architecture and sequences of human and mouse BNIP-2. A. Known or putative functional motifs indicated are: the
Rho-binding domain (RBD), Cdc42/Rac1-Interactive Binding (CRIB)-like motif, BCH signature motif, BCH/BCH interaction motif, caspase and granzyme
cleavage sites and kinesin-targeting motifs. Annotation of the RBD is based on close similarity to known RBDs in BNIP-2 homologs and Cdc42GAP. B.
ClustalW multiple sequence alignment of human and mouse BNIP-2 splice variants, i.e., the database annotated hBNIP2 sequence [Swiss-Prot: Q12982]
as well as short mBNIP-2 [Trembl: Q91VL0] and long mBNIP-2 [Swiss-Prot: O54940]. The black box highlights the P4-P9′ motif with the P4-P1 IEAD GrB
cleavage motif and BNIP-2 domains indicated as in A.
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bilities of BNIP-2 - identified in this study as an efficient
mGrB substrate - by the orthologous mouse and humangranzymes B and demonstrated that differential substrate
targeting of BNIP-2 by orthologous granzymes B is
strongly influenced by the primed site residues.
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Ethics statement
All results of this research were based on the use of
cultured human (HeLa or Jurkat) or mouse (NIH/3T3
or YAC-1) cell lines. Neither human (human subjects or
human derived material) nor animals (vertebrates or any
regulated invertebrates) were used in this experimental
research.
Cell culture
Human HeLa cells (ATCC CCL-2, American Type Culture
Collection, Manassas, VA, USA), mouse NIH/3T3 cells
(ATCC CRL-1658), human Jurkat cells (ATCC TIB-152)
and mouse YAC-1 cells (ATCC; TIB-160) were grown in
DMEM (HeLa and NIH/3T3) or RPMI-1640 (Jurkat
and YAC-1) medium, supplemented with 10% foetal
bovine serum (Invitrogen, Carlsbad, CA, USA), 100
units/ml penicillin (Invitrogen) and 100 μg/ml strepto-
mycin (Invitrogen). For proteome analyses, Jurkat cells
were grown in RPMI 1640 medium (Invitrogen, Carlsbad,
CA, USA, #61870-010) containing either natural, 13C6
or 13C6
15N4 L-arginine (Cambridge Isotope Labs, Andover,
MA, USA) at a concentration of 230 μM (i.e., 20% of its
suggested concentration in RPMI at which L-arginine to
proline conversion was not detectable). Media were sup-
plemented with 10% dialyzed foetal bovine serum (Invitro-
gen, 26400–044), 100 units/ml penicillin (Invitrogen) and
100 μg/ml streptomycin (Invitrogen). Cells were cultured
at 37°C and in 5% CO2 for at least six population dou-
blings to ensure complete incorporation of the labeled
arginine.
Preparation of cell lysates for N-terminal COFRADIC
analysis
SILAC-labeled Jurkat cells were pre-incubated with the
pan-caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-
fluoromethyl ketone (z-VAD-fmk) at a final concentration
of 50 μM for 15 min at 37°C, washed in D-PBS and
re-suspended at 7 × 106 cells per ml in 50 mM Tris–HCl
pH 8.0 and 100 mM NaCl. Cells were lysed by three
rounds of freeze-thawing. Supernatants, cleared by centri-
fugation for 10 min at 16,000 g, were treated with 200 nM
of mouse recombinant granzyme B (mGrB) for the
indicated time points at 37°C. Recombinant mGrB was
produced in Pichia pastoris as described previously [3].
Solid guanidinium hydrochloride was added to a final
concentration of 4 M in order to inactivate mGrB and
denature all proteins. Before mixing equal amounts of
samples, proteins were reduced and alkylated using
TCEP.HCl (1 mM final concentration (f.c.)) and iodoace-
tamide (2 mM f.c.) respectively, for 1 h at 30°C. Subse-
quent steps of the N-terminal COFRADIC protocol were
performed as described previously [25]. The proteome
was digested overnight at 37°C with sequencing-grade,modified trypsin (Promega, Madison, WI, USA) (enzyme/
substrate of 1/100 w/w).
LC-MS/MS analysis and data processing
ESI LC-MS/MS analysis was performed on an ESI-Q-TOF
Premier (Waters Corporation) mass spectrometer as
described before [26]. ESI-Q-TOF MS/MS peptide frag-
mentation spectra were converted to pkl files using the
Masslynx® software (version 4.1, Waters Corporation).
N-terminal peptides were identified using a locally in-
stalled version of the MASCOT database search engine
version 2.2.1 and the Swiss-Prot database (version 13.0
of UniProtKB/Swiss-Prot protein database, containing in
total 356,194 sequence entries from which 18,609 human
entries) was searched with restriction to human proteins.
The following search parameters were used. Peptide
mass tolerance was set at 0.2 Da and peptide fragment
mass tolerance at 0.1 Da with the ESI-QUAD-TOF as
selected instrument for peptide fragmentation rules
for the Q-TOF Premier data. Endoproteinase Arg-C/P
(i.e., no restriction towards arginine-proline cleavage)
was set as enzyme allowing one missed cleavage. Variable
modifications were pyroglutamate formation of N-
terminal glutamine, pyrocarbamidomethyl formation of
N-terminal alkylated cysteine, deamidation of aspara-
gine, acetylation and tri-deuteroacetylation of the
alpha-N-terminus. Fixed modifications were methionine
oxidation (sulfoxide), carbamidomethylation of cysteine,
tri-deuteroacetylation of lysine and, for identifying heavy
labelled peptides, [13C6] or [
13C6
15N4]-arginine were
additionally set as fixed modifications. Only peptide-
to-spectrum matches with MASCOT ion scores that
exceeded the corresponding MASCOT identity threshold
score (at 95% confidence level) and that were ranked one,
were withheld. In addition, spectra that received a low
MASCOT ion score (5 or less points above threshold for
identity) were further interrogated and only spectra that
contained b- and y- fragment ions covering a stretch of
at least three consecutive amino acids were considered
identified. The estimated false discovery rate by searching
decoy databases was typically found to lie between 2 and
4% on the spectrum level [27]. Whenever a peptide
matched to multiple members of a protein family (redun-
dancy), the protein entry reported (column ‘Protein de-
scription’, Additional file 1: Table S1) was according to its
alphabetical ranking. In each case, other matching protein
entries were reported under the column ‘Isoforms’. The
peptide intensity ratios were manually calculated from the
MS data in the Masslynx® software version 4.1 environ-
ment. In order to correct for small variations in initial pro-





of the 541 database-annotated protein N-terminal peptides
identified (peptides starting at position 1 or 2) were first
subjected to robust statistics using the base-2 logarithms
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(12C6/
13C6) and 0.009 (
12C6/
13C6
15N4), were used to correct
for the calculated ratios of all peptides identified. R was
used to calculate the probability distributions of log2
transformed N-terminal peptide ratios between the 1st
and 2nd time point (N(−0.003, 0.1451) (mean, stand-
ard deviation)) and between the 2nd and 3rd time
point (N(0.009, 0.1871)). Protease substrate intensity
ratios falling within the 98% probability interval of the
protein N-terminal peptide intensity ratios were consid-
ered as derived from efficiently cleaved sites (see Results
section and [8]). The mass spectrometry proteomics data
have been deposited to the ProteomeXchange Consortium
(http://proteomecentral.proteomexchange.org) via the
PRIDE partner repository [28] with the dataset identi-
fier PXD000204 and DOI 10.6019/PXD000204.
Immunoblot analysis
PBS washed Jurkat cells were re-suspended in 50 mM
Tris.HCl pH 8.0 and 100 mM NaCl and subjected to
three rounds of freeze thaw lysis. Supernatants, cleared
by centrifugation for 10 min at 16,000 g, were pre-treated
with 5 mM iodoacetamide for 15 min in the dark to avoid
downstream granzyme B mediated caspase activation [29].
Protein samples were subsequently treated with varying
concentrations of hGrB or mGrB (ranging from 0.97 nM
to 1 μM). Following GrB incubation, sample loading buffer
was added and equal amounts of protein (50 μg/sample;
protein concentrations were measured using the DC
Protein Assay Kit from Bio-Rad (Munich, Germany))
were separated on 4-12% or 12% polyacrylamide Criterion
XT-gels in MOPS buffer (Bio-Rad) at 150 V. Subse-
quently, proteins were transferred onto a PVDF mem-
brane. To detect endogenous Bid and BNIP-2 proteins,
membranes were blocked for 30 min in 5% skimmed milk
powder containing Tris-buffered saline and 0.1% Tween-
20 (TBS-T) and probed for 1 h with primary antibody in
5% skimmed milk powder in TBS-T. Following three
10 min washes in TBS-T, membranes were incubated with
species-specific HRP-conjugated antibody for 1 h in 5%
skimmed milk powder containing TBS-T. Again following
a 3-fold wash step in TBS-T or TBS (last wash step),
bands were visualized on ECL Hyperfilms (Amersham
Biosciences, Buckinghamshire, UK) using an enhanced
chemiluminiscence kit (PerkinElmer Life Sciences, Boston,
MA, USA). Bid antibody was from R&D systems (AF860)
and BNIP-2 antibody from Hypromatrix (HM1251).
Assessing BNIP-2 peptide substrate cleavage
An oligopeptide holding the hBNIP-2 GrB cleavage
site (italics) identified using N-terminal COFRADIC,
NH2.LPEDDSIEADILAITGY(NO2)R.OH, was synthesized
in-house using Fmoc-chemistry on an Applied Biosystems
433A Peptide Synthesizer. Cleavage progression wasassayed for 2 h at 37°C with various concentrations of
human and mouse GrB (50, 200 and 500 nM) at a
substrate concentration of 100 μM. The reactions were
stopped by adding trifluoroacetic acid to a final con-
centration of 1%. Cleavage by human and mouse GrB
was assessed by monitoring the UV absorbance signal
(214 nm) of the precursor peptide and its fragments
upon reverse-phase HPLC separation. The extent of
hydrolysis was determined from the intensity of the
product peak(s) compared to the intensity of their
unprocessed precursor.
Granzyme cleavage of in vitro transcribed and translated
BNIP-2
Vectors encoding wild type BNIP-2 (with or without 5′
leader) and BNIP-2 variants were used as templates for
in vitro coupled transcription/translation in a rabbit
reticulocyte lysate system according to the manufac-
turer’s instructions (IVTT; Promega) to generate [35S]
methionine-labeled BNIP-2 (variants). The TnT Quick
Master Mix (40 μl) (pOTB7-hBNIP-2 (RZPD Imagenes,
cat n° IRAUp969D059D, Germany) and pCMV-SPORT6-
mBNIP-2 (RZPD Imagenes, cat n° IRAVp968F0522D,
Germany)) – consisting of a rabbit reticulocyte lysate,
reaction buffer, SP6 or T7 RNA polymerase, an amino
acid mixture without methionine and RNasin Ribonucle-
ase Inhibitor – was mixed with 2 μl [35S]-methionine
(20 μCi/ml), 1 μg of plasmid DNA template (1 μg/μl) and
7 μl nuclease-free water. Following 90 min incubation
at 30°C, translates were incubated with iodoacetamide
(f.c. 5 mM) for 15 min at 37°C in the dark to avoid down-
stream caspase activation upon incubation with granzyme
B [30]. The translates (5 μl) were subsequently incubated
for 1.5 h at 37°C in granzyme assay buffer with varying
concentrations of hGrB or mGrB (ranging from 0.97 nM
to 1 μM) in a total volume of 30 μl. Cleavage reactions
were stopped by the addition of NuPAGE® LDS Sample
Buffer (Invitrogen) and by heating the samples for 10 min
at 70°C. Proteins were separated on 4-12% NuPAGE®
Bis-Tris gradient gels and subsequently transferred onto
a PVDF membrane as indicated above, air-dried and
exposed to a film suitable for radiographic detection
(ECL Hyperfilms, Amersham Biosciences, Buckingham-
shire, UK). The percentage of cleavage was determined
by densitometry following autoradiographic analysis.
Quantification was performed using the ChemiGenius
imaging system (SynGene, Cambridge, United Kingdom)
and signal intensity was quantified using GeneTools 3.07
image analysis software (SynGene).
Cloning of wild type BNIP-2 and BNIP-2 variants
Of note, the UniProtKB database contains entries of
two mouse BNIP-2 splice variants (Swiss-Prot O54940
(long mouse BNIP-2) and Trembl Q91VL0 (short mouse
Van Damme et al. BMC Biochemistry 2014, 15:21 Page 6 of 17
http://www.biomedcentral.com/1471-2091/15/21BNIP-2)) which only differ by 12 additional amino acid
residues at the C-terminus (Figure 1B). All experiments
conducted however (unless indicated otherwise) made use
of the short mBNIP-2 variant as this represents the closest
hBNIP-2 ortholog (Figure 1B). The pOTB7-hBNIP-2, the
pCMV-SPORT6-mBNIP-2 (short mouse BNIP-2) and the
pFLCI-mBNIP-2 (long mouse BNIP-2; RZPD Imagenes,
cat n° E330010L14) vectors served as templates to gener-
ate attB-flanked PCR products of full-length and mutated
BNIP-2 variants suitable for use in a Gateway® BP recom-
bination reaction with a donor vector (pDONR221, Invi-
trogen, cat n° 12536–017) thereby creating an entry clone.
Forward primers of human, short mouse and long mouse
BNIP-2 (with or without 5′ leader) and their respective re-
verse primers used to generate attB flanked PCR products
are indicated in Additional file 2: Table S2. Of note, short
and long mBNIP-2 reverse primers are identical and
therefore annotated as mBNIP-2 reverse primer. Add-
itional forward primers were designed to mimic the GrB
cleaved C-terminal human and mouse BNIP-2 fragment
(i.e., truncated h/m BNIP-2 or tBNIP-2), however add-
itionally encoding an extra N-terminal Met residue in
order for translation (initiation) to proceed, thereby giv-
ing rise to a tBNIP-2 with a Met-Ile- starting protein
N-terminus where Ile represents the P1′ Ile29 of GrB
cleaved full-length BNIP2. The reverse primers were
designed to fuse the desired PCR products in frame
with the C-terminal V5/His-tag encoded by the destin-
ation vector. To create BNIP-2 expression clones, the
BNIP-2 inserts of the entry vectors were recombined into
the pEF-DEST51 destination vector (Invitrogen, cat n°
12285–011) using LR-clonase (Invitrogen, cat n° 11791–
020) according to the manufacturer’s instructions.
Site-directed PCR-mutagenesis
Plasmids encoding the human to mouse specific mutations:
I29 > T, A31 > D, I32 > G, G34 > D, E36 > D and D37 > R as well
as combined mutants of hBNIP-2 were generated by
site-directed PCR-mutagenesis (QuickChange, Stratagene)
according to the manufacturer’s instructions using primer
pairs listed in Additional file 2: Table S2. To create the
hBNIP-2 mutant in which P1′, P6′ and P8′ are mutated,
the hBNIP-2 P1′ mutant was used as template and forward
and reverse primer pairs were created to generate this
combined mutant (Additional file 2: Table S2; combined
1). The hBNIP-2 mutant where all differential amino acids
C-terminal to the cleavage site were mutated to the corre-
sponding amino acids present in the murine BNIP-2
ortholog, also made use of the P1′ mutant as template. In
first instance, primer pairs were developed as to generate
a combined P1′, P3′, P4′, P6′ and P8′ mutant (Additional
file 2: Table S2; combined 2) upon which an additional
PCR reaction was conducted to mutate P9′ (Additional
file 2: Table S2; combined 3). In human and mouse (bothshort and long) BNIP-2 expression plasmids, next to mu-
tation of the database annotated AUG translation sites,
mutations in their 5′ leader sequence at the upstream
non-cognate (non-AUG) translation initiation sites
(uTIS) reported in [31,32] were created to monitor
BNIP-2 N-terminal isoform production (Additional file 2:
Table S2). The correctness of all (mutant) cDNA se-
quences generated was confirmed by DNA sequencing.
BNIP-2 expression
Human HeLa and mouse NIH/3T3 cells seeded one day
prior to transfection at 50 × 103 cells/well in a 12-well
plate, were transiently transfected for 24 h with 0.6 or
0.8 μg/ml (final concentration) of the eukaryotic expression
vectors using Fugene HD (Roche; cat. n° 04709705001)
according to the manufacturer’s instructions. After 28 h,
cells were lysed on-plate using 80 μl lysis buffer (50 mM
Tris–HCl (pH 7.8), 150 mM NaCl, 1% NP-40 and prote-
ase inhibitor cocktail tablet (Roche, cat n° 11697498001)),
subjected to three rounds of freeze-thaw lysis and centri-
fuged for 10 min at 16,000 g. Sample loading buffer was
then added and proteins were separated using 4‐12%
polyacrylamide Criterion XT‐gels (1.0 mm thick gels) in
MOPS buffer (Bio‐Rad) at 150 V. Subsequently, proteins
were transferred onto a PVDF membrane. Membranes
were blocked for 30 min in a 1:1 Tris‐buffered saline
and 0.1% Tween‐20 (TBS‐T) Odyssey Blocking solution
(LI-COR, cat n° 927–40003) and probed for 1 h with
primary anti-V5 antibody (Invitrogen, cat n° R960-25,
dilution: 1/5000) in TBS‐T/Odyssey blocking buffer.
Following three 10 min washes in TBS‐T, membranes
were incubated with secondary anti-mouse antibody
(IRDye 800 CW goat anti-mouse antibody IgG, LI-COR,
cat n° 926–32210) for 1 h in TBS‐T/Odyssey blocking
buffer followed by 3 washes in TBS‐T or TBS (last wash
step), bands were visualized using an Odyssey infrared
imaging system (LI-COR).
SLO mediated delivery of GrB
24 h before streptolysin-O (SLO)/GrB incubation, HeLa
and NIH/3T3 cells, plated one day before transfection at
50 × 103 cells/well in a 12-well plate, were transfected
with 0.6 and 0.8 μg BNIP-2 as described above. After
24 h, cells were washed twice with serum-free and
antibiotics-free DMEM medium and pretreated with
50 μM z-VAD-fmk for 15 min at 37°C to inhibit caspase
activation. Subsequently, cells were incubated with a
sublytic concentration of SLO (250 ng/ml) (as deter-
mined by flow cytometry; data not shown) and 200 nM
GrB for 30 min at 37°C. After 30 min, an equal volume
of DMEM containing 20% FCS (f.c. 10%) without antibi-
otics was added to inhibit SLO and cells were allowed to
recover for 1 h. Next, cells were lysed in SDS-PAGE
loading buffer (60 mM Tris pH 6.8, 10% glycerol and 2%
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at 16,000 g. Protein samples were further processed as
described above for immunoblot analysis and BNIP-2 was
visualized using an anti-V5 antibody (Invitrogen, cat n°
R960-25; 1/5000 dilution).
Results
Mouse granzyme B kinetic degradomics
Screening the degradome of mGrB in function of time
allows classifying substrate cleavage events according to
the efficiency by which they get cleaved [8]. Here, three
freeze-thaw Jurkat cell lysates differentially SILAC
(Stable Isotope Labeling by Amino acids in Cell culture




L-arginine were incubated with 200 nM mGrB for 10, 30
and 60 min respectively, as this allows monitoring the dy-
namics of mGrB generated neo-N-termini. Overall, this
analysis resulted in the identification of 2,312 MS/MS
spectra linked to 800 N-terminal peptides. Of these, 556
(or 70%) represent database annotated protein N-termini
(start position 1 or 2 and N-terminally modified with a(n)
(trideutero)acetyl group), while 199 N-termini (or 25%),
originating from 191 proteins hinted to proteolytic events,
potentially generated by mGrB, as these did not map to
position 1 or 2 while carrying a trideuteroacetyl moiety at
their N-terminus. The remaining 45 N-termini (or 5%)
might point to alternative translation initiation events due
to the presence of a co-translationally added N-terminal
acetyl moiety [34]. To assign mGrB-specific cleavage
events, all neo-N-termini were compared to a previous
compilation of GrB cleavage events, the latter additionally
making use of an internal control setup (i.e., a setup where
no GrB was added) [1]. As a result, 37 mGrB cleavage sites
in 36 human proteins could unequivocally be assigned.
In our setup, protein N-termini are generally not
expected to change over time and their corresponding
precursor ion intensities in MS should remain constant.
As such, mGrB generated neo-N-termini with similar
fold changes as compared to protein-N-termini point to
efficiently cleaved substrates as the concentration of
such neo-N-termini does not change upon prolonged
protease incubation [8]. Neo-N-termini with increasing
ion intensities in function of time can be considered as
less efficiently cleaved (i.e., the concentration of such neo-
N-termini increases upon prolonged protease incubation).
By taking the intra-experimental variation of the 541 data-





13C6 ratios could be calculated,
a 98% confidence interval could be applied to distinguish
efficient from less efficient mGrB cleavage sites (Figure 2).
As a result, 9 cleavage sites were assigned efficiently
cleaved as compared to 28 less efficiently cleaved (by-
stander) sites (Additional file 1: Table S1). In line with the
hypothesis that mGrB induced apoptosis mainly proceedsvia the activation of caspases [2,14], procaspase 7 appears
amongst the most efficiently cleaved mGrB substrates. As
expected, and in contrast to hGrB, (efficient) Bid cleavage
was not observed [2-4]. Interestingly, another pro-
apoptotic Bcl2-family member, BNIP-2 was found
amongst the most efficiently cleaved mGrB substrates, as
was the case for hGrB induced BNIP-2 cleavage [1,8].
More strikingly and in sharp contrast to the exclusive
hGrB mediated cleavage of hBid [4], hBNIP-2 was found
to be cleaved by mGrB at the identical and hGrB specific
P4-P1 hBid motif IEAD.
Cleavage efficiency of BNIP-2 by GrB: Biochemical
characterization of (murinized) BNIP-2 by oligopeptide
and substrate cleavage
Western blot analyses using either hGrB or mGrB incu-
bated human and mouse cell-free extracts validated our
proteomics findings (Figure 3 and [8]). Cleavage of
mBNIP-2 in mouse YAC-1 lysates however was not
observed since BNIP-2 protein expression could not be
detected even when using several BNIP-2 antibodies
targeting different epitopes (data not shown). Noteworthy,
both endogenous and recombinant BNIP-2 expression
patterns revealed the presence of multiple BNIP-2 vari-
ants, i.e., N-terminal extended BNIP-2 variants produced
by alternative translation initiation at near-cognate start
codons in the 5′ leader sequence as shown below. Overall,
whereas both orthologous granzymes efficiently target
hBNIP-2, human and mouse Bid processing could only be
observed for hGrB (Figure 3B and C). Since multiple pro-
teolytic BNIP-2 fragments could be observed (Figure 3A)
and in order to probe for GrB cleavage efficiencies at the
IEAD28 cleavage motif identified by positional proteomics,
peptides holding the hBNIP-2 P10-P6′ cleavage motif
were synthesized and challenged with human or mouse
GrB. Peptide cleavage analyses revealed that, while hold-
ing a hGrB specific P4-P1 hBid motif, mGrB did cleave
the hBNIP-2 peptide at IEAD28 (Figure 4). Taking into
account the greater cytotoxicity potential of hGrB versus
mGrB, and the fact that so far only 16% of all cleavages
identified in a proteome-wide degradomics screen were
found to be uniquely or more efficiently cleaved by mGrB,
mGrB cleaves the hBNIP-2 peptide about 5 times more
efficient as compared to hGrB [2,3] (Figure 4).
To assess the contribution of BNIP-2 primed site resi-
dues in steering hGrB and mGrB cleavage efficiencies,
(P’ mutants of) in vitro translated human [Swiss-Prot:
Q12982] and mouse [Trembl: Q91VL0] BNIP-2 were in-
cubated with varying concentrations of human or mouse
granzyme B. In analogy to cleavage efficiencies observed
when probing cell lysates, this analysis revealed efficient
hBNIP-2 cleavage by hGrB and mGrB, however add-
itionally demonstrated that mBNIP-2 was cleaved far less
efficient by hGrB (± a 25-fold reduction based on the
Figure 2 Efficiency classification of mGrB cleavage events. The distribution of 541 protein N-termini (green circles) and 37 mGrB specific




13C6 ratios could be calculated, are plotted. The spreading of the values for the
unaffected protein-N-termini was used to set the area containing the most efficiently cleaved mGrB sites (p ≤ 0.02). UniProtKB gene names are as
in Additional file 1: Table S1.
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http://www.biomedcentral.com/1471-2091/15/21amount of protease needed to cleave 50% of the substrate),
whereas both human and mouse BNIP-2 were cleaved with
similar mGrB cleavage efficiencies (Figure 5). Taken
together, this hints to the presence of (a) putative hGrB
discriminating substrate feature(s). Interestingly, compari-
son of the human and mouse BNIP-2 protein sequences
revealed a very high sequence similarity and identity of
96% and 93% respectively with the highest degree ofFigure 3 Probing granzyme B cleavage efficiencies of Bid and BNIP-2
mouse YAC-1 cells were incubated with serial dilutions (ranging from 1 μM
assess BNIP-2 (A: Jurkat) and Bid (B: Jurkat and C: YAC-1) cleavage. Precurso
represent GrB generated BNIP-2 cleavage fragments. BNIP-2 results in the Y
could be detected by means of immunoblotting (data not shown).divergence at the primed site sequence immediately
following the scissile bond (i.e., from P1′ to P9′, next to 5
non-conservative substitutions, only 3 identical and 1 con-
servative amino acid substitution are found, Figure 1B).
We therefore investigated the contribution of each
differing amino acid to GrB processing in the primed
extended specificity profile of the IEAD28 motif. Using
site-directed mutagenesis, we showed that the IEAA28in cell-free lysates. Alkylated freeze-thaw lysates of human Jurkat and
to 0.97 nM (from right to left)) of human and mouse granzyme B to
rs are indicated by black arrows, whereas dashed and grey arrows
AC-1 background are lacking since no endogenous BNIP-2 precursors
Figure 4 Granzyme B mediated cleavage of a peptide substrate holding the hBNIP-2 cleavage motif. Cleavage progression of the hBNIP-2
peptide substrate NH2.LPEDDSIEADILAITGY(NO2)R.OH was assayed for 2 h at 37°C with various concentrations of human and mouse GrB (50, 200
and 500 nM) at a substrate concentration of 100 μM, and its precursor and fragment peptides separated by RP-HPLC (chromatograms with
absorbance at 214 nm are shown). The grey arrow indicates (residual) precursor peptide, whereas black and dashed arrows indicate peptide
fragments generated upon human (upper panel) and mouse (lower panel) GrB mediated cleavage at IEAD (the dashed arrow corresponds to the
N-terminal fragment NH2.LPEDDSIEAD.OH, whereas the black arrow corresponds to the C-terminal fragment NH2.ILAITGY(NO2)R.OH).
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(Additional file 3: Figure S1). Next, we “murinized”
hBNIP-2 to investigate possible influences of the P1′-P9′
primed site motif on GrB-mediated BNIP-2 proteolysis
(Figure 6 and Additional file 4: Figure S2). These analyses
reveal that, although all analyzed P′ positions contribute
to the differences in mGrB/hGrB cleavage efficiencies
observed, the P3′ Ala31 to Asp mutation increases the
mGrB/hGrB ratio of cleavage over 15-fold, by and large
explaining the poor cleavage susceptibility of mBNIP-2 by
hGrB (Figure 6A). Furthermore, cleavage of this single
amino acid mutant by hGrB was about 5-fold reduced as
compared to cleavage of wild-type hBNIP-2, whereas
mGrB cleavage susceptibility was not affected. An Ile to
Thr mutation at the P1′ position yields the highest in-
crease in cleavage efficiency for both human and mouse
GrB as this variant was cleaved about 4-fold more efficient
by both orthologous granzymes as compared to wild-type
hBNIP-2 (Figure 6B). In addition, mutation of P6′ and P8′
amino acids to the corresponding mouse residues both
appeared favorable for cleavage by both granzymes as
compared to cleavage of wild-type hBNIP-2, whereas mu-
tation of the P9′ residue did not alter cleavage efficiency
(Additional file 4: Figure S2). The creation of combined
primed site mutants, such as the hBNIP-2 mutants
containing the mBNIP-2 P1′, P6′ and P8′ residues, or alldifferentiating primed site amino acids (Figure 7), also in-
creased the mGrB/hGrB cleavage ratio over 10-fold, indi-
cative for the fact that multiple primed site residues
contribute to the increased mGrB/hGrB cleavage ratio as
compared to hBNIP-2.
BNIP-2 cleavage upon SLO-mediated GrB delivery in cellulo
To assess if our in vitro findings can be extrapolated to
cell cultures and to corroborate the results reported by
Scott et al. [11] who demonstrated cleavage of hBNIP-2
by hGrB during natural killer mediated cell death, we
pursued GrB cleavage of overexpressed human and
mouse BNIP-2 by means of SLO-mediated GrB delivery
in HeLa and NIH/3T3 cells respectively (Figure 8). In-
deed, our results show that next to human BNIP-2, over-
expressed mouse BNIP-2 is efficiently cleaved during
human and mouse GrB induced cell death. Transfection
of truncated BNIP-2 (i.e., the GrB generated cleavage
fragment (tBNIP-2)) confirms cleavage at the IEAD28
motif of full-length BNIP-2. However, whereas previous
studies [11,23,24] reporting on the overexpression of
full-length and/or truncated hBNIP-2 led to moderate
poly (ADP) ribose polymerase 1 (PARP-1) cleavage and/or
caspase activation, indicative for apoptosis, when trans-
fecting (truncated) human and mouse BNIP-2 variants,
we were unable to observe caspase activity or any of the
Figure 5 Autoradiographs showing GrB induced cleavage of wild-type human and mouse BNIP-2. In vitro transcribed and translated
wild-type human and mouse BNIP-2 were incubated with varying concentrations (ranging from 3.9 nM to 1 μM (from left to right)) of human
and mouse GrB. Black arrows indicate BNIP-2 precursor patterns whereas dashed and grey arrows are indicative for BNIP-2 cleavage fragments.
Percentages of cleavage are shown in the progression curves of hGrB and mGrB cleavage and indicated by full and dashed lines respectively.
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pase assays and flow cytometry (data not shown).
Assessing the influence of 5′ leader sequences on BNIP-2
precursor patterns
In line with previous findings in various human cell lines
(i.e., NK and Daudi [11]) and when probing for en-
dogenous or in vitro translated BNIP-2, in each case
clearly distinguishable higher molecular BNIP-2 precursor
bands could be observed (Figures 3, 5, 6, 7 and 8). Previ-
ously, these BNIP-2 variants were hypothesized to result
from posttranslational modifications [35] or alternative
splicing, as is the case for two other BNIP-2 homologs
[36]. Of note also is the presence of two mBNIP-2 splice
variants in the UniProtKB database (here referred to as
short [Trembl: Q91VL0] and long mouse BNIP-2
[Swiss-Prot: O54940]), only differing in 12 additional
amino acids close to the C-terminus harbored in its
BCH domain (Figures 1B and 9A).
Genome-wide translation initiation profiling using Ribo-
Seq [31,32] however indicates that the higher molecular
weight BNIP-2 species might represent N-terminally ex-
tended BNIP-2 variants raised by alternative translation
initiation at near-cognate start codons in the 5′ leadersequence or presumed 5′UTR of BNIP-2. Ribosome
profiling allows sequencing of ribosome-protected mRNA
fragments [31] and, combined with the use of translation
inhibitors that cause accumulation of ribosomes at initi-
ation codons, the exact translation initiation sites and
ORFs can be delineated [31,32]. Genome-wide analyses of
in vivo translation in mouse embryonic stem cells and hu-
man Hek293t cells led to the identification of respectively
one human and two mouse upstream in-frame translation
initiation site(s) potentially giving rise to N-terminally
extended BNIP-2 variants (Figure 9A and Additional file 5
and Additional file 6: Figures S3 and S4). Since the
original expression plasmids did hold part of the 5′ leader
sequence (53% and 82% of the hBNIP-2 and mBNIP-2 5′
leader sequences respectively) (Additional file 5 and
Additional file 6: Figures S3 and S4), we wanted to
experimentally monitor translation initiation at the near-
cognate start codons upstream and in-frame of the data-
base annotated translation initiation start site (dbTIS).
Therefore, we created a mBNIP-2 expression plasmid de-
prived of its 5′ leader sequence and examined the precur-
sor profile upon transfection in human HeLa and mouse
NIH/3T3 cells (Figure 9B). Indeed, the higher molecular
weight precursor band could no longer be observed.
Figure 6 Autoradiographs showing GrB induced cleavage of murinized human BNIP-2 variants. P3′ (A) and P1′ (B) differing primed site
residues following the identified P4-P1 cleavage site IEAD in hBNIP-2 were mutated to their corresponding mBNIP-2 amino acids. The in vitro
transcribed and translated (mutated) BNIP-2 variants were incubated with varying concentrations (ranging from 1.95 nM to 1 μM (from left to
right)) of human or mouse granzyme B. Black arrows indicate BNIP-2 precursor patterns, whereas dashed and grey arrows are indicative for
BNIP-2 cleavage fragments. Percentages of cleavage are shown in the progression curves of hGrB and mGrB cleavage and indicated by full and
dashed lines respectively.
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http://www.biomedcentral.com/1471-2091/15/21Given that translation initiation at upstream TIS (uTIS)
A (a ctg codon in hBNIP-2 and atc in both mBNIP-2
variants) and uTIS B (tgg in hBNIP-2 and ctg in both
mBNIP-2 variants) or uTIS C (ctg in all BNIP-2 variants
studied) in theory increases the molecular weight of the
database annotated BNIP-2 by 7 kDa and 4.5 kDa respect-
ively (Figure 9A and Additional file 5 and Additional
file 6: Figures S3 and S4), these findings correlate well
with the different molecular weight precursor bands
observed when probing endogenous, overexpressed
and in vitro translated BNIP-2 (Figures 3, 5, 6, 7 and 8)
[11]. To investigate this in more detail, BNIP-2 transla-
tion products were assessed in HeLa and NIH/3T3
cells transfected with human and mouse BNIP-2 ex-
pression plasmids mutated at each of the putative uTIS
(uTIS A-C) reported (Figure 10). For hBNIP-2, transla-
tion initiation at uTIS C (ctg) (i.e., the uTIS reported
by ribosome profiling in Hek293t cells [32]) resulted in
the production of an N-terminally extended BNIP-2
variant. Mutation of the most upstream putative TIS
reported, uTIS A, however did not alter the precursor
pattern observed in the human and mouse BNIP-2 control
setups. Finally, mutation of the database annotated initiatormethionine in human and mouse BNIP-2 resulted in the
disappearance of the lowest molecular weight band
(Additional file 7: Figure S5). Overall, these analyses
unequivocally point to the use of alternative translation
initiation start sites in the 5′ leader of BNIP-2 leading
to the production of N-terminally extended BNIP-2
variants.
Discussion
Our current and previous degradome analyses led to the
identification of human BNIP-2, a pro-apoptotic Bcl-2
family member, as an efficient human and mouse gran-
zyme B substrate. For mGrB however, this represents an
unanticipated cleavage event given that neither human
nor mouse Bid are cleaved by mGrB whereas hBNIP-2 is
cleaved after the hGrB specific P4-P1 Bid tetrapeptide
motif IEAD. Up till now the P4-P1 specificity profile was
considered to be the main determinant for substrate
recognition. In this study, hBNIP-2 was found to be
efficiently processed by both orthologous granzymes B
at IEAD28. Interestingly, at the peptide-level mGrB was
found to cleave the hBNIP-2 specific peptide 5-fold
more efficiently as compared to hGrB. On the other
Figure 7 Autoradiographs showing GrB induced cleavage of combined primed site hBNIP-2 variants. In vitro transcribed and translated
combined hBNIP-2 variants were incubated with varying concentrations (ranging from 3.9 nM to 1 μM (from left to right)) of human and mouse
GrB. Black arrows indicate BNIP-2 precursor patterns whereas dashed and grey arrows are indicative for BNIP-2 cleavage fragments. Percentages
of cleavage are shown in the progression curves of hGrB and mGrB cleavage and indicated by full and dashed lines respectively.
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http://www.biomedcentral.com/1471-2091/15/21Figure 8 GrB induced BNIP-2 cleavage in cellulo. Human and mouse GrB delivered by means of SLO to human HeLa and murine NIH/3T3
cells transfected with hBNIP-2 and mBNIP-2 respectively were examined for in cellulo BNIP-2 cleavage. The in vitro (IV) hGrB induced cleavage
pattern of hBNIP-2 in transfected HeLa cell lysates as well as HeLa and NIH/3T3 cells transfected with the truncated hBNIP-2 and mBNIP-2 variants
respectively are included for comparison. Black arrows indicate BNIP-2 precursor patterns whereas dashed and grey arrows are indicative
for BNIP-2 cleavage fragments.
Figure 9 Upstream translation initiation sites (uTIS) in the 5’ leader sequences of BNIP-2. A. Domain architecture and BCH domains of
human and mouse BNIP-2 variants. In-frame translation products possessing a BCH domain were taken into account (i.e., four mouse (1–4) and
two human (5–6) BNIP-2 variants). From top to bottom: 1. UniProtKB accession long mBNIP-2 (O54940) complemented with the 5′ leader from
ENSMUSG00000011958; 2. Short mBNIP-2 [Trembl: Q91VL0]; 3. Long mBNIP-2 [Swiss-Prot: O54940]; 4. G5E8U9 (Trembl), 5. J3KN59 (Trembl) and 6.
Human BNIP-2 [Swiss-Prot: Q12982]. Red bars are indicative for 5′ leader sequences whereas A, B and C annotations refer to putative alternative
upstream translation initiation sites deduced from ribosome profiling analyses of a human (C) and mouse (A and B) cell line. B. Assessing the
influence of 5′ leader sequences on BNIP-2 precursor patterns. The involvement of upstream translation initiation (uTIS) in the appearance of
multiple precursor bands was investigated by transfecting BNIP-2 with or without its 5′ leader sequence in human HeLa and mouse NIH/3T3 cells.
Black arrows indicate BNIP-2 precursors.
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http://www.biomedcentral.com/1471-2091/15/21hand, hGrB appeared to process hBNIP-2 in cell-free
extracts more efficiently while mGrB processing of
in vitro translated human and mouse BNIP-2 exceeded
hGrB cleavage efficiencies over 25-fold. These discrepancies
in cleavage efficiencies are likely explained by structurally
different accessibilities of the cleavage site.
Structural analyses using IUPred [37], SEG [38] and
DisoPred [39], all predict the GrB targeted IEAD28 site
to reside in an unstructured/disordered region of the hu-
man and mouse BNIP-2 orthologs, a feature reminiscent
to the Bid IEAD75 motif residing in an unstructured/dis-
ordered region of the available crystal and NMR struc-
tures of Bid [40]. Strengthened by the observation that
all N-terminal extended BNIP-2 variants display equal
GrB cleavage susceptibilities, this implies that, if the
overall accessibility of the cleavage site is similar, bindingdifferences and thus differences in the mGrB and hGrB
cleavage efficiencies must be found in the detail of the
extended substrate motif recognized. Remarkably, the
most noteworthy sequence context differences between
the highly similar human and mouse BNIP-2 sequences
were found immediately C-terminal to the scissile bond
and more specifically from P1′ to P9′. While structural
modelling and molecular dynamics simulation cannot
reliably model the flexible N-terminus providing further
molecular insight, murinization of hBNIP-2 was done to
investigate the contribution of each differing amino acid
to the higher cleavage efficiency observed for mGrB.
Our data show the P3′ Ala to Asp mutation as the most
critical determinant for the observed differences in
mGrB/hGrB mediated mBNIP-2 cleavage. On the other
hand, next to amino acids present in the P6′ and P8′
Figure 10 Assessing the influence of 5′ leader sequences on BNIP-2 precursor patterns. The contribution of alternative translation initiation
to the multiple precursor bands was assessed by transfecting HeLa and NIH/3T3 cells with various uTIS mutated BNIP-2 expressing constructs.
Whereas mutation of uTIS A did not alter the precursor pattern observed in the human and mouse BNIP-2 control setups, mutation of uTIS B
(black arrow) resulted in the disappearance of the precursor band with the highest MW in murine BNIP-2 variants. The dashed arrow is indicative
for the N-terminally extended BNIP-2 variant raised upon translation initiation at uTIS C. The BNIP-2 Swiss-Prot database annotated precursor band
is annotated with a grey arrow (cfr. Additional file 7: Figure S5).
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http://www.biomedcentral.com/1471-2091/15/21position, the largest increase in cleavage efficiency was
obtained when mutating Ile in the P1′ position to Thr.
These results are in accordance with the previously
reported extended substrate specificity profiles of human
and mouse GrB [1], where a preference for small resi-
dues was found at the P1′ position next to a preference
for acidic residues from the P3′ position onwards, thus
validating the increased cleavage susceptibility of mGrB
and hGrB observed when mutating amino acids in the
P1′ and P6′ positions to threonine and aspartic acid
respectively. Combination of primed site mutations in-
creased mGrB/hGrB cleavage ratios over 10-fold (as com-
pared to wild type hBNIP-2 cleavage; i.e., P1′, P6′ and P8′
residues) hinting to primed site substrate cooperativity
steering GrB cleavage. Further, substitution of all differing
hGrB primed site residues following Asp28 by the entire
murine primed cassette resulted in cleavage efficiencies
approaching those observed for mGrB cleavage of
mBNIP-2. Furthermore, BNIP-2 cleavage in a cellular
context was shown to occur upon SLO-mediated GrB
delivery, hinting to its physiological relevance.
Comparing kinetic degradomics data of human and
mouse GrB obtained in an identical proteome back-
ground showed that among the efficiently targeted GrB
cleavage sites identified, four were shared between mGrB
(Additional file 1: Table S1) and hGrB [8]. While three
out of four were found processed with similar efficien-
cies, human granzyme B cleavage of caspase-7 was
found to proceed less efficiently. More specifically, the
neo-N-terminus generated upon granzyme B cleavage
(S199GPINDTDANPR) carries a glycine residue at the
P2′ position which was previously shown by us and
others [3,8] to be preferred by mGrB, and thus explainsthe higher efficiency of mGrB/hGrB cleavage observed
by means of kinetic degradome analyses [8]. An obser-
vation in line with the assumption that mGrB induced
apoptosis mainly proceeds via the activation of cas-
pases [2,14].
Interestingly, multiple BNIP-2 precursor bands were
observed for endogenous and in vitro translated or over-
expressed BNIP-2 in HeLa and NIH/3T3 cells. The
omnipresence of alternative translation initiation [41]
and the recent finding of potential uTIS within the 5′
leader sequence of BNIP-2 [31,32], led us to investigate
whether translation at the reported uTIS were causative
for the composite BNIP-2 precursor patterns observed.
Transfection of an eukaryotic mBNIP-2 expression vec-
tor depleted of the 5′ leader sequence indeed confirmed
the usage of at least one uTIS leading to the creation of
an N-terminally extended form of the database anno-
tated BNIP-2 sequence, an observation further validated
when overexpressing various human and mouse BNIP-2
uTIS mutants in HeLa and NIH/3T3 cells. In the current
study, translation initiation at uTIS A, the most upstream
uTIS determined by ribosome profiling in mice, could not
be observed. This difference could well be explained by
the fact that the original BNIP-2 expression constructs
only hold part of the 5′ leader sequences, thus potentially
lacking regulatory sequences promoting translation initi-
ation at this site [42]. The potential importance of amino
terminal BNIP-2 extensions can be exemplified by the
observation that an N-terminally extended Bid splice vari-
ant has an altered subcellular localization potentially
influencing cellular apoptosis [43]. Strikingly, we also
observed a cell context dependency of TIS usage, the
regulation of which requires follow-up studies. Next,
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the GrB generated BNIP-2 fragments induce PARP-1
cleavage upon transfection in HeLa cells [11]. Of note
however, expression of (t)BNIP-2 resulted only in a
very low percentage of PARP-1 cleavage [11]. Moreover, a
24 h transfection of the empty vector or a mock control
transfection clearly also resulted in PARP-1 cleavage
which approximated (t)BNIP-2 induced PARP-1 cleavage.
In this study, none of the techniques suitable for the
detection and/or quantification of the degree of apoptosis
applied, were capable of detecting evidence of cell death
in BNIP-2 or tBNIP-2 transfected human (HeLa) and
murine (NIH/3T3) cells while positive controls (stauros-
porin to induce apoptosis) did result in an apoptotic read-
out, questioning the (cell-type dependent) role of BNIP-2
in apoptotic signaling.
Conclusions
The differential cleavage susceptibilities of BNIP-2 by
orthologous granzymes B can be explained by the pres-
ence of different primed site residues in the mouse and
human BNIP-2 orthologs, in accordance with differen-
tial subsite requirements observed for both granzymes
[1-4]. Whether mBNIP-2 plays a pivotal role in mGrB
induced cell death and how alternative translation
initiation of BNIP-2 affects BNIP-2 function remains
to be elucidated.
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Additional file 1: Table S1. Classification of 37 mGrB generated
neo-N-termini and their corresponding substrates. The UniProtKB/Swiss-Prot
database primary accession number, protein description, P10-P10′ sequence
and fold change of the mGrB generated neo-N-termini are given between
10 and 30 min and between 30 and 60 min. For each category, proteins are
ranked alphabetically according to their protein description. Additional
information on the maximum score, identity threshold, isoforms and whether
these identical cleavage sites were previously found in the N-terminal
COFRADIC analyses screening for efficient hGrB cleavage sites/substrates [8]
and analyses on hGrB, mGrB and mGrC respectively are listed [5].
Additional file 2: Table S2. List of primers used to design mutants and
attB PCR flanked products. Mutated nucleotides are underlined.
Additional file 3: Figure S1. Autoradiographs showing the resistance
of human and mouse BNIP-2 IEAA28 mutants to GrB induced cleavage. In
vitro transcribed and translated human and mouse BNIP-2 IEAA28 mutants
were incubated with varying concentrations (ranging from 3.9 nM to 500
nM (from right to left)) of human or mouse GrB. Black arrows indicate
BNIP-2 precursor patterns.
Additional file 4: Figure S2. Autoradiographs showing GrB induced
cleavage of murinized human BNIP-2 variants. P4′, P6′, P8′ and P9′ differing
primed site residues following the identified P4-P1 cleavage site IEAD in
hBNIP-2 were mutated to their corresponding mBNIP-2 amino acids. In vitro
transcribed and translated BNIP-2 variants were incubated with varying
concentrations (ranging from 1.95 nM to 1 μM (from left to right)) of humanor mouse granzyme B. Black arrows indicate BNIP-2 precursor patterns,
whereas dashed and grey arrows are indicative for BNIP-2 cleavage
fragments. Percentages of cleavage are shown in the progression
curves of hGrB and mGrB cleavage and indicated by full and dashed
lines respectively.
Additional file 5: Figure S3. ClustalW multiple sequence alignment of
human and mouse BNIP-2 variants. The amino acid sequences of the
longest hBNIP-2 annotated protein (annotated as hBNIP-2; UniProtKB
accession [Trembl: J3KN59]) as well as the N-terminally extended uTIS
variants of hBNIP2 [Swiss-Prot: Q12982] were used in the alignment. The
longest mBNIP-2 variant is based on O54940 (Swiss-Prot) complemented
with the 5′ leader from ENSMUSG00000011958 whereas other variants of
mBNIP-2 (short mouse BNIP-2 [Trembl: Q91VL0] and long mBNIP-2
[Swiss-Prot: O54940]) are depicted together with their postulated N-terminal
extensions. The black box highlights the P4-P1 IEAD recognition motif
whereas the red box assigns the database annotated initiator Met of mouse
and human BNIP-2 proteins.
Additional file 6: Figure S4. Cloned sequences of human (A), short
mouse (B) and long mouse (C) BNIP-2. Alternative translation initiation
sites are indicated in italics. Red and green letters denote the putative
upstream translation initiation sites identified by means of ribosome
profiling in mouse and human cells respectively. Below each nucleotide
sequence, amino acid sequences of putative translation products are
given.
Additional file 7: Figure S5. Assessing the influence of 5′ leader
sequences on BNIP-2 precursor patterns. Assignment of the precursor band
corresponding to the database annotated protein (human BNIP-2:[Swiss-Prot:
Q12982], short mouse BNIP-2:[Trembl: Q91VL0] and long mouse BNIP-2:
[Swiss-Prot: O54940]) by mutating their respective initiator methionines. A grey
arrow points to the UniProtKB annotated BNIP-2 variants, while black and
dashed arrows indicate the BNIP-2 variants associated with translation initiation
at uTIS B and uTIS C respectively.
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N-Benzyloxycarbonyl-Val-Ala-Asp (O-methyl) fluoromethyl ketone.
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